Liang et al. (2019) found in the colorectal cancer model that DOP can enhance the metabolic ability of tumor infiltrating CD8+ CTL, reduce the loss of mitochondria the expression of PD-1 on CTL, thus enhancing the anti-tumor immune response of TME. The gene discussed is CD8A; the disease is neoplasm.